Targeted prostate cancer treatment cuts risk of side effects, study suggests

An NHS trial over 10 years followed nearly 3,500 men who received focal therapy, a less invasive treatment.

Partagez cet article

Leave a Reply

Your email address will not be published. Required fields are marked *